Department of Nutrition and Dietetics, The University of Auckland, Faculty of Medical and Health Sciences, Auckland, New Zealand.
Starship Blood and Cancer Centre, Starship Child Health, Auckland, New Zealand.
J Hum Nutr Diet. 2025 Feb;38(1):e13273. doi: 10.1111/jhn.13273. Epub 2024 Jan 7.
Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy in the world. Advances in treatment protocols have resulted in survival rates of >80% in most high-income countries (HIC); however, children and young people (CYP) with ALL continue to face significant nutrition-related challenges during treatment.
This narrative review outlines the changing landscape of treatment and survivorship for CYP with ALL and the advances in nutrition knowledge that call for changes to clinical nutrition practice.
The incidence of ALL has remained stable in HIC; however, there have been significant advances in survival over the past 30 years. Overweight and obesity are increasingly prevalent in CYP with ALL at diagnosis, during treatment and in survivorship. Coupled with poor diet quality, high-energy and saturated fat intakes, altered eating behaviours and inactivity, this necessitates the need for a shift in nutrition intervention. Undernutrition remains a concern for CYP with high-risk treatment protocols where oral or enteral nutrition support remains a cornerstone of maintaining nutrition status.
With improved treatment protocols and high survival rates, a shift to focusing on diet quality, prevention of excessive weight gain and obesity during treatment and survivorship is necessary.
急性淋巴细胞白血病(ALL)是世界上最常见的儿科恶性肿瘤。在治疗方案方面的进步使得大多数高收入国家(HIC)的生存率超过 80%;然而,ALL 患儿和青少年(CYP)在治疗期间仍然面临着严重的营养相关挑战。
本文综述概述了 ALL 患儿和青少年治疗和生存状况的变化,以及营养知识的进步,这些进步要求改变临床营养实践。
在 HIC,ALL 的发病率保持稳定;然而,在过去 30 年中,生存率有了显著提高。超重和肥胖在 ALL 患儿中的发病率越来越高,在诊断时、治疗期间和生存期间均如此。再加上饮食质量差、高能量和饱和脂肪摄入、改变的饮食习惯和不活动,这就需要改变营养干预措施。对于接受高风险治疗方案的 CYP,营养不良仍然是一个问题,其中口服或肠内营养支持仍然是维持营养状态的基石。
随着治疗方案的改进和生存率的提高,有必要将重点转向饮食质量、预防治疗期间和生存期间过度体重增加和肥胖。